BioCompute Objects: Tools for Communicating Next Generation Sequencing Data and Analysis

The 2019 BioCompute Workshop, co-sponsored by the U.S. Food and Drug Administration (FDA), the George Washington University, and the BioCompute Partnership


On May 14, 2019, the United States Food and Drug Administration (FDA), together with the George Washington University, will co-sponsor the 2019 BioCompute Workshop, entitled "BioCompute Objects: Tools for Communicating Next Generation Sequencing Data and Analysis." The Workshop will be held on the FDA's White Oak campus, 10903 New Hampshire Ave., Bldg. 31 Conference Center, room 1503 A, Silver Spring, MD 20993. Parking and security information can be found here. Space is limited, so please register soon to guarantee a seat. Limited WebEx spots are also available.

The full agenda for the workshop can be seen here.
To register for the Workshop, please visit this link. For more information, contact Omar Zuber at the FDA, or Jonathon Keeney at George Washington University.





BACKGROUND:

In 2013, the FDA's Genomics Working Group outlined specific goals for a mechanism to resolve complications in submitting next generation sequencing (NGS) data to a regulatory body like the FDA. Biocompute Objects were developed conceptually to address the tremendous need for clearly articulating bioinformatic workflows in a manner that was transparent and allowed for reproducibility and verification. The development of Biocompute Objects seeks to set a common standard for communicating bioinformatic analysis pipelines. The BioCompute project has become a model of collaborative communication and has grown to include participants from many institutions in both the public and private sectors, including biotech, pharmaceutical, government agencies, and academia. The Workshop builds on nearly 5 years of collaborative work to help streamline the way that bioinformatics analyses are communicated.

The BioCompute project has resulted in three prior workshops, two publications, several collaborations, and is currently undergoing formal balloting to become an official IEEE standard. The upcoming Workshop will engage more stakeholders in creating and using BioCompute for NGS and other bioinformatics data analysis communications with the FDA. Specifically, the Workshop will have two components: use case examples, and hands on & demonstrations of new tools that leverage BioCompute. A new Precision FDA-BioCompute Challenge will also be launched at the event.